Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPI-613 in advanced bile duct cancers
NCT01766219Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of devimistat in cholangiocarcinoma (CCA), sponsored by Wake Forest University Health Sciences. Started May 2013; status: completed.
02
Drugs
devimistat
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT01766219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766219.